Using an enzalutamide-resistant cell model (C4-2-EnzR), our investigations revealed that STARD4 overexpression markedly potentiated the inhibitory effects of enzalutamide on PCa cells and reversed enzalutamide resistance. The gene discussed is STARD4; the disease is posterior cortical atrophy.